Task Force Immune Checkpoint Inhibitor Toxicity

Immune checkpoint inhibitors are a breakthrough in cancer treatment, but some do cause side effects. In this UPMC Physician Journal feature, see members of a unique task force in action as they tackle rare and life-threatening conditions that could be brought on by checkpoint inhibitors. This story includes interviews with Fang Sun, MD, PhD, UPMC Neurology and assistant professor of Neurology, University of Pittsburgh School of Medicine; Joshua Levenson, MD, FACC, Director, UPMC, Center for Cardio-Oncology; and Diwakar Davar, MD, MS, UPMC-Clinical Director of the Melanoma and Skin Cancer Program and associate professor of Medicine, University of Pittsburgh School of Medicine.

View All Episodes

Click here to return to the series home page.

Did You Train at UPMC or Pitt?

Sign up to stay connected through our alumni communications.